α-Glucosidase-IN-29
α-Glucosidase-IN-29 (compound 19) is a α-glucosidases inhibitor (IC50=1.21 μM, Ki=1.80 μM) . α-Glucosidase-IN-29 ca be used for research of diabetes and related diseases[1].
Product Specifications
CAS Number
2949513-11-3
UNSPSC
12352005
Target
Glycosidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/α-glucosidase-in-29.html
Solubility
10 mM in DMSO
Smiles
OC(C1=CC=CC=C1O2)=C(C(C3=CC(Br)=C(OCCCCCCCC)C(Br)=C3)C4=C(O)C(C=CC=C5)=C5OC4=O)C2=O
Molecular Formula
C33H30Br2O7
Molecular Weight
698.40
References & Citations
[1]Phan TH, et al. Designing Potent -Glucosidase Inhibitors: A Synthesis and QSAR Modeling Approach for Biscoumarin Derivatives. ACS Omega. 2023 Jul 11;8 (29) :26340-26350.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
M9699-64T-FITC 100 µL
Mycobacterium tuberculosis (M. tuberculosis, Putative Virulence-Regulating 38kD Protein, virS, Rv3082c, MT3167, MTV013.03c) (FITC)
Sign In for Pricing
View Details